Palantir's Karp renews attacks on frontier AI labs that are 'trying to drug addict us'
Palantir's Karp escalates: frontier labs are 'trying to drug addict us' with distilled models — and have no moral standing to criticize Chinese distillation.
Why it matters
High-profile criticism of frontier lab business practices (model distillation, lock-in strategies) from a major enterprise AI player signals growing tension over openness, IP, and competitive dynamics in the lab-race ecosystem.
The key facts
11 to knowKarp frames frontier labs' distillation as extracting 'all the value of IP, everywhere'
Karp defends Chinese models' right to distill U.S. models given frontier labs' own practices
Rhetoric: 'trying to drug addict us' — suggests lock-in/dependency strategy accusation
Palantir (major enterprise AI player) publicly attacking OpenAI/Anthropic business model
Distillation and open-weight strategy becoming flashpoint in lab-race drama
Karp attacks frontier labs for 'distilling all the value of IP, everywhere'
Defends Chinese models' right to distill U.S. models given frontier labs' own practices
Uses addiction metaphor for frontier labs' strategy ('trying to drug addict us')
Positions Palantir as alternative to frontier lab dependency
Part of ongoing Karp criticism of OpenAI, Anthropic, and open-weight ecosystem
Published August 2026 — indicates ongoing market/strategic tension
Go to the source
CNBC Technologycnbc.com
Publisher excerpt: Karp said Chinese models can't be blamed for distilling U.S. models when the frontier labs "distilled all the value of IP, everywhere."